LSL Pharma Group Inc (LSL) Stock Statistics & Valuation Metrics

LSL Pharma Group Inc has a market cap or net worth of CAD 39.92M. The enterprise value is CAD 89.55M.

Market Cap

CAD 39.92M

Enterprise Value

CAD 89.55M

LSL Pharma Group Inc has 126,729,820 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

126,729,820

Owned by Insiders

0.43%

Owned by Institutions

―

LSL Pharma Group Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

349.234

Employee Count

252

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, LSL Pharma Group Inc had revenue of ― and earned 88.01K in profits. Earnings per share was ―.

Revenue

―

Gross Profit

507.58K

Operating Income

809.27K

Pretax Income

―

Net Income

88.01K

EBITDA

990.62K

Earnings Per Share (EPS)

―

Beta

0.49

52-Week Price Change

-11.27%

50-Day Moving Average

0.31

200-Day Moving Average

0.37

Relative Strength Index (RSI)

57.69

Average Volume (3m)

38.80K

LSL Pharma Group Inc upcoming earnings date is Dec 01, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 25, 2026

Next Earnings Date

Dec 01, 2026

Ex-Dividend Date

―

LSL Pharma Group Inc has ― in cash and marketable securities with CAD 10.57M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 10.57M

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for LSL Pharma Group Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

80.01%

EPS Growth Forecast

-289.64%